$RGNX 4 SEC Filings

Filed On	Filing
03 Sep 2026	Form 4: Malzahn Craig, Chief Technology Officer Gave up 234 shares to cover exercise price or tax ($2.18K)
03 Sep 2026	Form 4: Chan Mitchell, Chief Financial Officer Gave up 4,902 shares to cover exercise price or tax ($45.7K)
27 Aug 2026	Form 4: Ciongoli Gregory Austin, Director Received 15,432 shares as a grant or award · Granted 69,609 Stock Options (Right to buy) · Bought 49,196 shares ($450K) · 1 more
04 Aug 2026	Form 4: Pakola Steve, Chief Medical Officer Gave up 7,468 shares to cover exercise price or tax ($72.4K)
04 Aug 2026	Form 4: Christmas Patrick J., Chief Strategy & Legal Officer Gave up 4,699 shares to cover exercise price or tax ($45.5K)
06 Jul 2026	Form 4: Pakola Steve, Chief Medical Officer Received 2,161 shares by exercise or conversion ($17K) · Sold 2,161 shares ($29.5K)
06 Jul 2026	Form 4: Simpson Curran, Director Received 951 shares as a grant or award ($6.65K) · Received 1,453 shares as a grant or award ($14.8K) · Gave up 6,818 shares to cover exercise price or tax ($89.2K)
01 Jul 2026	Form 4: Pakola Steve, Chief Medical Officer Sold 19,608 shares ($216K) · Received 36,725 shares by exercise or conversion ($289K) · Sold 36,725 shares ($472K)
02 Jun 2026	Form 4: Tasse Daniel, Director Received 9,807 shares as a grant or award · Granted 46,600 Stock Options (Right to Buy)
02 Jun 2026	Form 4: Stump David C, Director Received 9,807 shares as a grant or award · Granted 46,600 Stock Options (Right to Buy)
02 Jun 2026	Form 4: Zachary Jennifer, Director Received 9,807 shares as a grant or award · Granted 46,600 Stock Options (Right to Buy)
02 Jun 2026	Form 4: Mills Kenneth T., Director Received 9,807 shares as a grant or award · Granted 46,600 Stock Options (Right to Buy)
02 Jun 2026	Form 4: Migausky George V, Director Received 9,807 shares as a grant or award · Granted 46,600 Stock Options (Right to Buy)
02 Jun 2026	Form 4: Karabelas Argeris N, Director Received 9,807 shares as a grant or award · Granted 46,600 Stock Options (Right to Buy)
02 Jun 2026	Form 4: Glucksmann Alexandra, Director Received 9,807 shares as a grant or award · Granted 46,600 Stock Options (Right to Buy)
02 Jun 2026	Form 4: Fox Allan M., Director Received 9,807 shares as a grant or award · Granted 46,600 Stock Options (Right to Buy)
02 Jun 2026	Form 4: Bennett Jean, Director Received 9,807 shares as a grant or award · Granted 46,600 Stock Options (Right to Buy)
13 May 2026	Form 4: Pakola Steve, Chief Medical Officer Sold 15,309 shares ($169K)
12 Mar 2026	Form 4: Pakola Steve, Chief Medical Officer Sold 5,124 shares ($53K)
03 Feb 2026	Form 4: Pakola Steve, Chief Medical Officer Gave up 5,267 shares to cover exercise price or tax ($58.8K)

Comments